COCH
Price
$6.74Alerts
Change
-$0.07 (-1.03%)
Updated
Nov 13 closing price
Capitalization
553.37M
143 days until earnings call
Intraday BUY SELL Signals
VVOS
Price
$0.10Alerts
Change
-$0.00 (-0.00%)
Updated
Nov 13 closing price
Capitalization
1.89M
4 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

COCH vs VVOS

COCH vs VVOS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
COCH vs. VVOS commentary
Nov 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is COCH is a Hold and VVOS is a StrongBuy.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for COCH with price predictions
Nov 13, 2026

COCH sees its 50-day moving average cross bearishly below its 200-day moving average

The 50-day moving average for COCH moved below the 200-day moving average on October 30, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 23 of 50 cases where COCH's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 46%.

COCH moved below its 50-day moving average on November 13, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where COCH declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

COCH broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for COCH entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on November 02, 2026. You may want to consider a long position or call options on COCH as a result. In 44 of 93 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 47%.

The Moving Average Convergence Divergence (MACD) for COCH just turned positive on October 27, 2026. Looking at past instances where COCH's MACD turned positive, the stock continued to rise in 26 of 48 cases over the following month. The odds of a continued upward trend are 54%.

The 10-day moving average for COCH crossed bullishly above the 50-day moving average on November 10, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 16 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 62%.

Following a +3.38% 3-day Advance, the price is estimated to grow further. Considering data from situations where COCH advanced for three days, in 119 of 180 cases, the price rose further within the following month. The odds of a continued upward trend are 66%.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. COCH’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 99 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: COCH's P/B Ratio (149.803) is very high in comparison to the industry average of (4.142). P/E Ratio (-9.408) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (192.308) is also within normal values, averaging (40.124).

The Tickeron PE Growth Rating for this company is 100 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. COCH’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

A.I.Advisor
a Summary for VVOS with price predictions
Nov 13, 2026

VVOS's RSI Oscillator recovers from oversold territory

The RSI Indicator for VVOS moved out of oversold territory on November 12, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 56 similar instances when the indicator left oversold territory. In 48 of the 56 cases the stock moved higher. This puts the odds of a move higher at 86%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

The Moving Average Convergence Divergence (MACD) for VVOS just turned positive on November 13, 2026. Looking at past instances where VVOS's MACD turned positive, the stock continued to rise in 34 of 40 cases over the following month. The odds of a continued upward trend are 85%.

Following a +8.29% 3-day Advance, the price is estimated to grow further. Considering data from situations where VVOS advanced for three days, in 183 of 222 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

VVOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VVOS as a result. In 70 of 76 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VVOS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for VVOS entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 33 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-0.383) is normal, around the industry mean (4.142). P/E Ratio (-0.050) is within average values for comparable stocks, (3.291). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.253). Dividend Yield (0.000) settles around the average of (0.011) among similar stocks. P/S Ratio (0.108) is also within normal values, averaging (40.124).

The Tickeron Seasonality Score of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Price Growth Rating for this company is 95 (best 1 - 100 worst), indicating slightly worse than average price growth. VVOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VVOS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.

FUNDAMENTALS RATINGS
VVOS: Fundamental Ratings
VVOS
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
95
P/E GROWTH RATING
1..100
6
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
COCHVVOS
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
46%
Bullish Trend 2 days ago
83%
Momentum
ODDS (%)
Bullish Trend 2 days ago
47%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bullish Trend 2 days ago
54%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
70%
Bullish Trend 2 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
44%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 13 days ago
66%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 2 days ago
80%
Bearish Trend 9 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
49%
Bullish Trend 2 days ago
86%
Aroon
ODDS (%)
Bearish Trend 2 days ago
81%
Bearish Trend 2 days ago
90%
COMPARISON
Comparison
Nov 15, 2026
Stock price -- (COCH: $6.74 vs. VVOS: $0.10)
Brand notoriety: COCH and VVOS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: COCH: 78% vs. VVOS: 32%
Market capitalization -- COCH: $553.37M vs. VVOS: $1.89M
COCH [@Medical/Nursing Services] is valued at $553.37M. VVOS’s [@Medical/Nursing Services] market capitalization is $1.89M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $190.22B. The average market capitalization across the [@Medical/Nursing Services] industry is $6.17B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

COCH’s FA Score shows that 0 FA rating(s) are green while VVOS’s FA Score has 2 green FA rating(s).

  • COCH’s FA Score: 0 green, 5 red.
  • VVOS’s FA Score: 2 green, 3 red.
According to our system of comparison, VVOS is a better buy in the long-term than COCH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

COCH’s TA Score shows that 4 TA indicator(s) are bullish while VVOS’s TA Score has 5 bullish TA indicator(s).

  • COCH’s TA Score: 4 bullish, 6 bearish.
  • VVOS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, VVOS is a better buy in the short-term than COCH.

Price Growth

COCH (@Medical/Nursing Services) experienced а -5.80% price change this week, while VVOS (@Medical/Nursing Services) price change was +4.59% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +1.37%. For the same industry, the average monthly price growth was -4.49%, and the average quarterly price growth was -5.80%.

Reported Earning Dates

COCH is expected to report earnings on Apr 06, 2027.

VVOS is expected to report earnings on Nov 18, 2026.

Industries' Descriptions

@Medical/Nursing Services (+1.37% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

COCH and

Correlation & Price change

A.I.dvisor tells us that COCH and VVOS have been poorly correlated (+26% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that COCH and VVOS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To COCH
1D Price
Change %
COCH100%
-1.10%
VVOS - COCH
26%
Poorly correlated
+2.40%
XWEL - COCH
25%
Poorly correlated
-4.42%
PHG - COCH
25%
Poorly correlated
+0.97%
PSNL - COCH
23%
Poorly correlated
-0.95%
BVS - COCH
22%
Poorly correlated
-1.84%
More

VVOS and

Correlation & Price change

A.I.dvisor tells us that VVOS and QDEL have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that VVOS and QDEL's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VVOS
1D Price
Change %
VVOS100%
+2.40%
QDEL - VVOS
31%
Poorly correlated
+1.13%
PODD - VVOS
29%
Poorly correlated
+2.14%
COCH - VVOS
26%
Poorly correlated
-1.10%
SHC - VVOS
26%
Poorly correlated
+1.90%
OFIX - VVOS
25%
Poorly correlated
+3.31%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LKFT33.980.05
+0.15%
Lakefront Biotherapeutics
TRC17.20-0.09
-0.52%
Tejon Ranch Co
BYAH1.45-0.02
-1.36%
Park Ha Biological Technology Co Ltd
ALB93.53-1.32
-1.39%
Albemarle Corp
VATE4.57-0.29
-5.97%
INNOVATE Corp